Notably, overexpression of LATS1 abrogated PDS5B knockdown-induced tumor promotion in NSCLC cells, suggesting that LATS1 is involved in PDS5B-mediated anticancer activity in lung cancer. Here, PDS5B is linked to lung cancer.